MedTrace Logo

Clinical Evaluation of Remineralizing Potential of Remineralizing Agents on WSLs Managment

NCT07111403 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-08-13

No results posted yet for this study

Summary

To evaluate and compare the clinical effect of four different remineralizing agents on initial enamel caries after a two years follow up.

Conditions

  • Initial Dental Caries
  • White Spot Lesion of Tooth

Interventions

PROCEDURE

SAP fluoride plus

The agent was applied by removing the safety clip, activating the applicator and squeezing out the sponge above the lesion and the solution was left to diffuse for 5 min.the patients were instructed to eat only soft foods and avoid hot liquids for two hours. Also, they were educated and motivated about the importance of oral hygiene.

PROCEDURE

10% n-HAp.

the pastes were applied using micro brushes. The excess was removed after four minutes with a cotton swab. The subjects were advised not to drink or eat for 30 minutes after the treatment. The treatment was applied once every week for a period of four weeks.they instructed to adhere to oral hygiene measures.

PROCEDURE

10% n-BAG.

the pastes were applied using micro brushes. The excess was removed after four minutes with a cotton swab. The subjects were advised not to drink or eat for 30 minutes after the treatment. The treatment was applied once every week for a period of four weeks. patients instructed to adhere to oral hygiene measures.

PROCEDURE

Flour Protector S

After application of varnish, the patient was instructed to avoid abrasive diet for the rest of the day and not brush or floss until the next morning. The treatment was done at baseline and after 6 months.

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Tarek A Arisha, Ass Lecturer · Faculty of Dentistry, Mansoura University, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-10
Primary Completion
2026-09-10
Completion
2026-09-17

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07111403 on ClinicalTrials.gov